Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

7 projects found matching your search criteria :

  1. Do miRNA determine cell fate during unfolded protein response (UPR) ?

    Call: OPUS 9 , Panel: NZ3

    Principal investigator: dr hab. Rafał Bartoszewski

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  2. The role of the PERK-eIF2alpha pathway in the survival and cancerogenic potential of Bcr-Abl expressing cells - in vivo ...

    Call: PRELUDIUM 1 , Panel: NZ4

    Principal investigator: dr Monika Kusio-Kobiałka

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  3. The Role of the Mitochondrial Unfolded Protein Response (UPRmt) in Endothelial Function: a Possible Novel Target for the...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Sylwester Mosiołek

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  4. Deciding the cell fate during UPR - are we barking up the wrong tree?

    Call: OPUS 19 , Panel: NZ3

    Principal investigator: prof. Rafał Bartoszewski

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  5. Evaluation of endoplasmic reticulum stress control by endogenous lipids in the context of its anticancer therapeutic pot...

    Call: OPUS 17 , Panel: NZ5

    Principal investigator: dr Dariusz Pytel

    Uniwersytet Medyczny w Łodzi, Międzywydziałowa Katedra Chemii i Biochemii Medycznej

  6. Linking abnormal Ca2+ signaling and the unfolded protein response with Huntington's disease pathology in both YAC128 mou...

    Call: OPUS 17 , Panel: NZ3

    Principal investigator: dr Magdalena Czeredys

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

  7. The role of endoplasmic reticulum stress in the pathomechanisms of early-life stress-induced dysfunction of the prefrona...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Chocyk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk